ACU193

1 stories · following the connections

Business

Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate

By Nasdaq OMXMar 1, 2018, 1:05 PM UTC